SGLT2 Inhibitors Increase Haemoglobin and Erythropoietin Levels
Sodium-glucose cotransporter 2 inhibitors are associated with modest increases in haemoglobin and haematocrit levels, according to a meta-analysis of 85 randomised clinical trials published in JAMA. The study examined 70,543 ... Read More